A Covidien (NYSE:COV) shareholder yesterday filed a purported class action lawsuit seeking to block the medical device company's pending $43 billion merger with Medtronic (NYSE:MDT).
Richard Taxman accuses Covidien, its board of directors and chairman, president & CEO José Almeida of breaching their fiduciary duties in agreeing to the acquisition, which values COV shares at $93.22 apiece.
Help employers find you! Check out all the jobs and post your resume.
